Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HPGD | P15428 | 3/20 | 0.38 |
| ▸ | RAB9A | P51151 | 3/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.35 |
| ▸ | SLC9A1 | P19634 | 2/20 | 0.35 |
| ▸ | NPC1 | O15118 | 3/20 | 0.33 |
| ▸ | CASP3 | P42574 | 1/20 | 0.33 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.33 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.33 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 4/20 | 0.33 |
| ▸ | LMNA | P02545 | 2/20 | 0.33 |
| ▸ | TSHR | P16473 | 2/20 | 0.33 |
| ▸ | LIMK1 | P53667 | 1/20 | 0.33 |
| ▸ | USP2 | O75604 | 1/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | HTT | P42858 | 1/20 | 0.33 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 3/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10053984 | 0.98 | HPGD (0.37) | HPGDRAB9ASMN1; SMN2KDM4EALDH1A1 | |
| SCHEMBL10054564 | 0.86 | SLC9A1 (0.36) | HPGDRAB9ASMN1; SMN2KDM4EALDH1A1 | |
| SCHEMBL10054567 | 0.84 | SLC9A1 (0.35) | HPGDRAB9ASMN1; SMN2KDM4EALDH1A1 | |
| SCHEMBL10053976 | 0.77 | LIMK1 (0.37) | HPGDLMNATSHRLIMK1HIF1A | |
| SCHEMBL10053974 | 0.77 | BACE1 (0.37) | HPGDRAB9ASMN1; SMN2ALDH1A1NPC1 | |
| SCHEMBL10053978 | 0.76 | LIMK1 (0.36) | LIMK1DHFR | |
| SCHEMBL10053975 | 0.76 | BACE1 (0.35) | HPGDRAB9ASMN1; SMN2ALDH1A1NPC1 | |
| SCHEMBL22675054 | 0.75 | HPGD (0.39) | HPGDRAB9ASMN1; SMN2KDM4EALDH1A1 | |
| SCHEMBL19521963 | 0.75 | ALDH1A1 (0.36) | RAB9ASMN1; SMN2KDM4EALDH1A1SLC9A1 | |
| SCHEMBL14882392 | 0.73 | ALDH1A1 (0.35) | HPGDRAB9AALDH1A1NPC1CASP3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8982443-B2 | Organic compound and electrochromic device including the same | CANON KABUSHIKI KAISHA (JP) | 2015-03-17 | — | — | US | disclosed |
| US-8982443-B2 | Organic compound and electrochromic device including the same | CANON KABUSHIKI KAISHA (JP) | 2015-03-17 | — | — | US | disclosed |
| US-20130100517-A1 | NOVEL ORGANIC COMPOUND AND ELECTROCHROMIC DEVICE INCLUDING THE SAME | CANON KABUSHIKI KAISHA (JP) | 2013-04-25 | — | — | US | disclosed |
| US-20130100517-A1 | NOVEL ORGANIC COMPOUND AND ELECTROCHROMIC DEVICE INCLUDING THE SAME | CANON KABUSHIKI KAISHA (JP) | 2013-04-25 | — | — | US | disclosed |
| WO-2012002185-A1 | NOVEL ORGANIC COMPOUND AND ELECTROCHROMIC DEVICE INCLUDING THE SAME | CANON KABUSHIKI KAISHA (JP) | 2012-01-05 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130100517-A1 | NOVEL ORGANIC COMPOUND AND ELECTROCHROMIC DEVICE INCLUDING THE SAME | CCNL2, DNMT3L, ARL1 | HPGD 4658/4885RAB9A 755/4885SMN1; SMN2 3079/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.